Healthcare orgs hardest hit by mobile device downtime Ponemon/Imprivata research finds
Posted:
Digital identity company Imprivata, and Ponemon Institute, today unveiled new research that highlights security, financial, and operational consequences associated with existing enterprise-owned mobile device programmes. Read the full article here.
The Food and Drug Administration approved a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable to life-threatening infections.
Read more here.
OpenAI launched ChatGPT Health and Anthropic added medical toolsets for Claude, meaning users can sync their records and wearables, using their personal health data to get hyper-specific answers to their medical questions. At the same time, the FDA issued new guidance…
Attendees
Sponsors and Exhibitors
Contact us